Home ServicesProductTechnology
Company
AboutTeamNews Contact
Real grayscale microscopy footage shows a culture-medium sample spiked with white blood cells and cancer cells flowing left to right through the Labyrinth chip, with white blood cells directed to outlet 1, cancer cells to outlet 2, and larger cells and clusters to outlet 3.

REAL MICROSCOPY · CELL TRACKING OVERLAY

See cell separation in action.

Real grayscale microscopy footage shows a culture-medium sample spiked with white blood cells and cancer cells flowing left to right through the Labyrinth chip, with white blood cells directed to outlet 1, cancer cells to outlet 2, and larger cells and clusters to outlet 3.

Labyrinth One
BloodScan Labyrinth One

Intact CTCs, Real Tumor Biology

From stage 0 to stage 4, BloodScan’s Labyrinth One system isolates intact circulating tumor cells (CTCs) directly from blood. For patients where tissue biopsy is unsafe, impractical, or impossible, we provide a safe, non-invasive, biopsy-equivalent alternative.

Learn More About Labyrinth One
Universal in Advanced Cancer

Near-Perfect Sensitivity Across Stage IV Solid Tumors

BloodScan achieves near-100% capture of circulating tumor cells in stage IV breast, lung, pancreatic, and virtually all solid cancers—providing the most reliable tumor signal in advanced disease.

Detects the Earliest Cancers

The Only CTC Technology Proven to Detect Pre-Invasive Lesions

Our Labyrinth system uniquely identifies circulating tumor cells from the earliest stages—even in pre-invasive conditions such as DCIS and early HCC—reaching beyond the limits of traditional liquid biopsy.

Biopsy-Level Insights

97% Genomic Concordance with Matched Tissue

BloodScan’s intact CTCs preserve real tumor biology, delivering tissue-equivalent genomic and treatment-relevant insights through a simple blood draw.

Learn More About Our Technology

How It Works

STEP 1

A standard blood draw into EDTA or other compatible vacutainer tubes.

STEP 2

Automated CTC isolation with Labyrinth One

STEP 3

Intact, viable cells ready for histology, genomics, and advanced assays

News

BloodScan CEO Eric Lin Joins Former President Tsai Ing-wen on a Silicon Valley Panel on Building Companies Across Taiwan and the US

During her visit to the San Francisco Bay Area, former Taiwan President Tsai Ing-wen met with young Taiwanese working and building companies…

Read More →